Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

US Patent 9895312 · Granted Feb 20, 2018

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

EGFL6 specific monoclonal antibodies and methods of their use2024
DNA aptamers and use thereof for the treatment of cancer2024
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2021
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2021
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2021
Dual assembly nanoparticles2020
EGFL6 specific monoclonal antibodies and methods of their use2020
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2020
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2020
Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant o2020
Bioreactor vessel for large scale growing of plants under aseptic condition2018
Axial and circumferential flaw sensing eddy current probe2016